HOME >> BIOLOGY >> NEWS
'Protecting virus' offers instant flu protection and converts flu infections into their own vaccines

e RNA of one of these 8 strands.

This deletion makes the virus harmless and prevents it from reproducing by itself within a cell, so that it cannot spread like a normal influenza virus. However, if it is joined in the cell by another influenza virus, it retains its harmless nature but starts to reproduce and at a much faster rate than the new influenza virus. This fast reproduction rate spurred by the new flu infection means that the new invading influenza is effectively crowded out by the 'protecting virus'. This vastly slows the progress of the new infection, prevents flu symptoms, and gives the body time to develop an immune response to the harmful new invader. In effect the protecting virus converts the virulent virus into a harmless live vaccine.

Research indicates that the 'protecting virus' would have the same beneficial effect whatever strain of influenza is infecting you. This is because the coat of the virus is irrelevant to the protection process the effect works on the virus genes inside the cell. It thus promises to be a highly effective tool when combating the spread of any new strain of virus, as well existing strains. One could give it as a preventive measure without the need to tailor it to a particular flu strain or mutation. This has obvious benefits when dealing with the sudden outbreak of a major epidemic, as one would not need to know the exact make up of the new strain before deploying the protecting virus making it much more useful than vaccines, which are effective only against particular existing strains of virus. In addition it protects instantly, whereas protection generated by conventional flu vaccination takes 2-3 weeks to become fully effective. Experiments so far show that a single dose of protecting virus can be given 6 weeks before an infection with flu virus and be effective. This could also have a substantial advantage over anti-viral drugs that only give less than 24-hour protection. Another
'"/>

Contact: Peter Dunn
p.j.dunn@warwick.ac.uk
2-476-52-3708
University of Warwick
4-Oct-2006


Page: 1 2 3

Related biology news :

1. Expert to provide update after worst tomato virus hits California
2. UF scientists identify cancer virus genetic targets
3. Proteins tail may be flu viruss achilles heel
4. Clue found to Epstein-Barr virus ability to form and sustain tumors
5. UCF nanoparticle offers promise for treating glaucoma
6. Lucky 13 as new gene discovery offers further hope for childhood blindness
7. Largest synthetic gene ever built offers insights into anti-malarial drug resistance
8. Gene therapy offers new hope for treatment of peripheral neuropathy
9. Study of protein folds offers insight into metabolic evolution
10. Soy estrogens and breast cancer: Researcher offers overview
11. NIST building software offers green product advice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead ... near term focus on Type 2 diabetes and associated comorbidities. , Justin brings ... areas and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in ... on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor ... live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition ...
(Date:7/1/2020)... ... 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit ... aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John ... the organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the ... the history of eSource, the reasons it did not take off as quickly as ... source, the industry is moving towards capturing data electronically for clinical trials and then ...
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/10/2020)... ... 2020 , ... In most research using the zebrafish model, ... in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the past ... the zebrafish model to investigate the causes of leukaemia and its relationship with ...
Breaking Biology Technology:
Cached News: